Mesocarb

This classification denotes a dopamine agonist with the molecular formula C18H18N4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) UMT8MP2NDU, chemically known as sydnone imine, 3-(alpha-methylphenethyl)-n-(phenylcarbamoyl)- but more generally known as mesocarb, which bears US NIH Compound Identifier 71932. European Medicines Agency schedules Mesocarb in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08785MIG. The term MESOCARB is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 30, No. 10 1976, List 16). MESOCARB is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule mesocarb under HS 29349100 and SITC 51579. As of Q4 2014, MESOCARB remains US FDA's Preferred Term for this commodity. Mesocarb bears US NLM identifiers UMLS ID C0074500 and NCI Concept Code C83937. SMILES: O1N[N](C(CC2CCCCC2)C)CC1/N=C(\O)NC1CCCCC1.